Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation
- 5 January 2010
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 109 (4), 774-781
- https://doi.org/10.1002/jcb.22456
Abstract
Recent data suggest that megakaryocytes (MKs) play a role in skeletal homeostasis. In vitro and in vivo data show that MKs stimulate osteoblast (OB) proliferation and inhibit osteoclast (OC) formation, thus favoring net bone deposition. There are several mouse models with dysregulated megakaryopoiesis and resultant high bone mass phenotypes. One such model that our group has extensively studied is GATA‐1 deficient mice. GATA‐1 is a transcription factor required for normal megakaryopoiesis, and mice deficient in GATA‐1 have increases in immature MK number and a striking increase in bone mass. While the increased bone mass could simply be a result of increased MK number, here we take a more in depth look at the MKs of these mice to see if there is a unique factor inherent to GATA‐1 deficient MKs that favors increased bone deposition. We show that increased MK number does correspond with increased OB proliferation and decreased OC formation that stage of maturation does not alter the effect of MKs on bone cell lineages beyond the megakaryoblast stage, and that GATA‐1 deficient MKs survive longer than wild‐type controls. So while increased MK number in GATA‐1 deficient mice likely contributes to the high bone mass phenotype, we propose that the increased longevity of this lineage also plays a role. Since GATA‐1 deficient MKs live longer they are able to exert both more proliferative influence on OBs and more inhibitory influence on OCs. J. Cell. Biochem. 109: 774–781, 2010.Keywords
This publication has 57 references indexed in Scilit:
- The role of gap junctions in megakaryocyte-mediated osteoblast proliferation and differentiationBone, 2009
- Platelet Dysfunction and a High Bone Mass Phenotype in a Murine Model of Platelet-Type von Willebrand DiseaseThe American Journal of Pathology, 2008
- Osteoclast formation and bone resorption are inhibited by megakaryocytesBone, 2006
- Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse modelsBest Practice & Research Clinical Haematology, 2006
- Fibroblasts Express RANKL and Support Osteoclastogenesis in a COX-2-Dependent Manner After Stimulation With Titanium ParticlesJournal of Bone and Mineral Research, 2005
- Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotypeBone, 2005
- Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblastsArthritis & Rheumatism, 2004
- Characterization of Monoclonal Antibodies Against Mouse and Rat Platelet Glycoprotein V (CD42d)Hybridoma, 2000
- Potential Role of Cbfa1, an Essential Transcriptional Factor for Osteoblast Differentiation, in Osteoclastogenesis: Regulation of mRNA Expression ofOsteoclast Differentiation Factor(ODF)Biochemical and Biophysical Research Communications, 1998
- Influence of cytokines (IL‐1α, IL‐3, IL‐11, GM‐CSF) on megakaryocyte‐fibroblast interactions in normal human bone marrowEuropean Journal of Haematology, 1995